EHA 2019: BELLINI Trial Evaluates Addition of Venetoclax to Bortezomib/Dexamethasone in Relapsed or Refractory Multiple Myeloma By The ASCO PostPosted: 6/19/2019 2:36:52 PMLast Updated: 6/19/2019 2:37:43 PM Key Points The median progression-free survival was 22.4 months in patients treated with the venetoclax combination vs 11.5 months in patients…
Patients treated recently for a B-lymphoid malignancy are shown to have particularly high risks of severe COVID-19 compared to multiple control cohorts of patients with…
Senate Vote #118 in 1971, in the United States Congress.
Non alcoholic steatohepatitis (NASH) is the inflammatory reaction of the liver to excessive accumulation of lipids in the hepatocytes. NASH can progress to c…
Mohamed Hendawi Aurora Cancer Care, Advocate Aurora Health, Milwaukee, WI Mohamed Hendawi, Luke Peterson, Eyob ale Tadesse, Frank M. Wolf, Thomas D. Brown, Michael A.…
Eyob ale Tadesse Aurora Cancer Care, Advocate Aurora Health, Milwaukee, WI Eyob ale Tadesse, Kayla Heslin, Mohamed Hendawi, Luke Peterson, Frank M. Wolf, Thomas D.…
Cancer Reports is an open access oncology journal for basic, translational and clinical research in cancer biology, diagnosis, treatment, outcome, and epidemiology.
By Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al., Published on 05/20/20
With all the viruses going around, when you start feeling sick you may wonder if it is just a cold or something more serious. According…
By Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al., Published on 05/20/20
Patients treated recently for a B-lymphoid malignancy are shown to have particularly high risks of severe COVID-19 compared to multiple control cohorts of patients with…
